1. Occupational support following arthroplasty of the lower limb (OPAL): trial protocol for a UK-wide phase III randomised controlled trial.
- Author
-
Sheehan L, Woodward A, Archer M, Jordan C, Martland M, McDonald DA, Parkinson G, Watkins L, Adamson J, Drummond A, Hewison A, Keding A, Kottam L, Madan I, McDaid C, Reed M, Sinclair L, Smith TO, Thomson L, Wu Q, and Baker P
- Subjects
- Humans, United Kingdom, Cost-Benefit Analysis, Return to Work, Arthroplasty, Replacement, Knee rehabilitation, Arthroplasty, Replacement, Hip rehabilitation, Arthroplasty, Replacement, Hip methods
- Abstract
Background: In the UK, one in four patients are in work at the time of their hip or knee replacement surgery. These patients receive little support about their return to work (RTW). There is a need for an occupational support intervention that encourages safe and sustained RTW which can be integrated into National Health Service practice. We developed a two-arm intervention trial, based on a feasibility study, to assess whether an occupational support intervention (the OPAL (Occupational support for Patients undergoing Arthroplasty of the Lower limb) intervention) is effective in supporting a reduced time to full, sustained RTW compared with usual care in patients undergoing hip and knee replacement., Methods and Analysis: This is a multicentre, individually randomised controlled superiority trial comparing the OPAL intervention to usual care. 742 working adults listed for elective primary hip or knee replacement, who intend to RTW, will be randomised to the OPAL intervention or usual care. The intervention comprises: (1) multimedia information resources; and (2) support from a designated RTW coordinator. The primary outcome is time until 'full' sustained RTW without sick leave for a consecutive 4-week period. Secondary outcomes are: time to any RTW, measures of functional recovery, number of 'sick days' between surgery and 'full' sustained RTW and the use of workplace modifications to facilitate their return. A health economic evaluation and a mixed methods process evaluation will assess cost-effectiveness and the implementation, fidelity and acceptability of the intervention, respectively. Outcomes will be collected at baseline, 3, 6, 9 and 12-month follow-up time points, as well as a monthly RTW questionnaire., Ethics and Dissemination: Dissemination will focus on supporting the wider adoption and implementation of the intervention (if effective) and will target groups for whom the results will be relevant. This trial was approved by West Midlands-Edgbaston REC 23/WM/0013., Trial Registration Number: ISRCTN13694911., Competing Interests: Competing interests: Professor Catriona McDaid is a Senior Journal Editor at NIHR Journals Library. All the other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.)
- Published
- 2024
- Full Text
- View/download PDF